Colon Cancer: Combination Chemotherapy With or Without Atezolizumab in Treating Patients
With Stage III Colon Cancer and Deficient DNA Mismatch Repair
What are the good and bad effects of using the drug atezolizumab along with the usual
chemotherapy, FOLFOX, compared to the usual chemotherapy, FOLFOX, alone?
Basic Study Information
Purpose:Location: Cancer Center
This study has 2 groups. Group 1 will receive the usual chemotherapy treatment of
FOLFOX plus the drug atezolizumab for 6 months, then patients will take atezolizumab
alone for an additional 6 months. Group 2 will receive the usual chemotherapy which
is FOLFOX for 6 months.
Study Web URL: https://clinicaltrials.gov/ct2/show/study/NCT02912559?term=A021502&rank=1&show_locs=Y#locn
Study Reference #: CGIC17112
Lead Researcher (Principal Investigator)
Lead Researcher: Mohamedtaki Tejani, MD
Study Contact InformationStudy Coordinator: Tanya Smith
Phone: (585) 275-8213
Additional Study Details
Learn More About These Conditions
More information about Colon Cancer
Trial Not Found
The study you are looking for is not active at this time.
Return to Search